CVS Health is expected to report a year-over-year increase in earnings and revenue for the quarter ended June 2026, with the Zacks Earnings ESP model indicating a likely beat. The consensus estimate calls for earnings of $1.87 per share, up 3.3% from the prior year, on revenues of $100.18 billion, a 1.3% increase. The Most Accurate Estimate is higher than the consensus, yielding an Earnings ESP of +1.42%, and the stock carries a Zacks Rank of 2, a combination that historically produces a positive surprise nearly 70% of the time. CVS Health has beaten consensus EPS estimates in each of the last four quarters, including a 16.29% surprise in the most recent period. The company is scheduled to release results on August 5.
CVS Health CorpExpected earnings beat and positive ESP/Zacks Rank combination suggest strong upcoming earnings report.
Revvity Inc.